1. The α1 adrenoceptor antagonist prazosin enhances sleep continuity in fear-conditioned Wistar–Kyoto rats
- Author
-
Nicholas D. Gajewski, Richard J. Ross, Graziella L. Mann, Adrian R. Morrison, Benjamin M. Laitman, and Leszek Kubin
- Subjects
Male ,Sleep Wake Disorders ,Rapid eye movement sleep ,Rats, Inbred WKY ,Article ,Stress Disorders, Post-Traumatic ,Norepinephrine (medication) ,Conditioning, Psychological ,mental disorders ,Prazosin ,medicine ,Animals ,Fear conditioning ,Biological Psychiatry ,Pharmacology ,Electroshock ,Sleep Stages ,musculoskeletal, neural, and ocular physiology ,Central nucleus of the amygdala ,Electroencephalography ,Immobility Response, Tonic ,Fear ,Brain Waves ,Sleep in non-human animals ,Rats ,Disease Models, Animal ,Anesthesia ,Adrenergic alpha-1 Receptor Antagonists ,Anxiety ,medicine.symptom ,Sleep ,Psychology ,psychological phenomena and processes ,medicine.drug - Abstract
Fragmentation of rapid eye movement sleep (REMS) is well described in individuals with posttraumatic stress disorder (PTSD) and likely has significant functional consequences. Fear-conditioned rodents may offer an attractive model of the changes in sleep that characterize PTSD. Following fear conditioning (FC), Wistar-Kyoto (WKY) rats, a strain known to be particularly stress-sensitive, have increased REMS fragmentation that can be quantified as a shift in the distribution of REMS episodes towards the more frequent occurrence of sequential REMS (inter-REMS episode interval ≤ 3 min) vs. single REMS (interval > 3 min). The α1 adrenoceptor antagonist prazosin has demonstrated efficacy in normalizing sleep in PTSD. To determine the utility of fear-conditioned WKY rats as a model of sleep disturbances typical of PTSD and as a platform for the development of new treatments, we tested the hypothesis that prazosin would reduce REMS fragmentation in fear-conditioned WKY rats. Sleep parameters and freezing (a standard measure of anxiety in rodents) were quantified at baseline and on days 1, 7, and 14 following FC, with either prazosin (0.01 mg/kg, i.p.) or vehicle injections administered prior to testing in a between-group design. Fear conditioning was achieved by pairing tones with a mild electric foot shock (1.0 mA, 0.5 s). One, 7, and 14 days following FC, prazosin or vehicle was injected, the tone was presented, freezing was measured, and then sleep was recorded from 11 AM to 3 PM. WKY rats given prazosin, compared to those given vehicle, had a lower amount of seq-REMS relative to total REMS time 14 days after FC. They also had a shorter non-REMS latency and fewer non-REMS arousals at baseline and on days 1 and 7 after FC. Thus, in FC rats, prazosin reduced both REMS fragmentation and non-REMS discontinuity.
- Published
- 2014
- Full Text
- View/download PDF